Literature DB >> 12767583

Communication and consumer decision making about cancer clinical trials.

Terrance L Albrecht1, John C Ruckdeschel, Dawn L Riddle, Christina G Blanchard, Louis A Penner, Michael D Coovert, Gwendolyn Quinn.   

Abstract

Communication between patients and physicians likely mediates traditional patient and physician predispositions in determining patient outcomes, including perceptions and decision making. However, the extent to which a mediating effect occurs is unclear. The purpose of this essay is to outline the need for conceptualizing more holistic models of consumer-provider interaction that demonstrate the role of the therapeutic relationship in treatment outcomes. We focus on an important communicative context for exploring this question: the situation where patients, with the help of oncologists, are faced with making treatment choices, particularly whether to enroll in a clinical trial in response to their life-threatening cancer diagnosis. We explore the question from the perspectives of the medical provider, the patient, and the accompanying family member, in order to better frame the complex interactional dynamics occurring during the interaction.

Entities:  

Mesh:

Year:  2003        PMID: 12767583     DOI: 10.1016/s0738-3991(03)00078-8

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  12 in total

1.  Discussing molecular testing in oncology care: Comparing patient and physician information preferences.

Authors:  Ana P M Pinheiro; Rachel H Pocock; Jeffrey M Switchenko; Margie D Dixon; Walid L Shaib; Suresh S Ramalingam; Rebecca D Pentz
Journal:  Cancer       Date:  2017-01-31       Impact factor: 6.860

2.  Testing the utility of a cancer clinical trial specific Question Prompt List (QPL-CT) during oncology consultations.

Authors:  Richard F Brown; Carma L Bylund; Yuelin Li; Shawna Edgerson; Phyllis Butow
Journal:  Patient Educ Couns       Date:  2012-03-04

Review 3.  Recommendations for enhancing clinical trials education: a review of the literature.

Authors:  Karen A Stepan; Amy P Gonzalez; Vivian S Dorsey; Debra K Frye; Nita D Pyle; Regina F Smith; Terry A Throckmorton; Louise A Villejo; Scott B Cantor
Journal:  J Cancer Educ       Date:  2011-03       Impact factor: 2.037

4.  Using Metaphors to Explain Molecular Testing to Cancer Patients.

Authors:  Ana P M Pinheiro; Rachel H Pocock; Margie D Dixon; Walid L Shaib; Suresh S Ramalingam; Rebecca D Pentz
Journal:  Oncologist       Date:  2017-02-20

5.  Influence of clinical communication on patients' decision making on participation in clinical trials.

Authors:  Terrance L Albrecht; Susan S Eggly; Marci E J Gleason; Felicity W K Harper; Tanina S Foster; Amy M Peterson; Heather Orom; Louis A Penner; John C Ruckdeschel
Journal:  J Clin Oncol       Date:  2008-06-01       Impact factor: 44.544

6.  Patient enrollment onto clinical trials: the role of physician knowledge.

Authors:  Justin R Gregg; Leora Horn; Mario A Davidson; Jill Gilbert
Journal:  J Cancer Educ       Date:  2014-03       Impact factor: 2.037

7.  Improving awareness of cancer clinical trials among Hispanic patients and families: audience segmentation decisions for a media intervention.

Authors:  Gwendolyn P Quinn; Jessica McIntyre; Luis E Gonzalez; Teresita Muñoz Antonia; Prado Antolino; Kristen J Wells
Journal:  J Health Commun       Date:  2013-05-02

8.  Can consultation skills training change doctors' behaviour to increase involvement of patients in making decisions about standard treatment and clinical trials: a randomized controlled trial.

Authors:  P Butow; R Brown; J Aldridge; I Juraskova; P Zoller; F Boyle; M Wilson; J Bernhard
Journal:  Health Expect       Date:  2014-06-30       Impact factor: 3.377

9.  Perceptions of participation in a phase I, II, or III clinical trial among African American patients with cancer: what do refusers say?

Authors:  Richard F Brown; Debbie L Cadet; Robert H Houlihan; Maria D Thomson; Emily C Pratt; Amy Sullivan; Laura A Siminoff
Journal:  J Oncol Pract       Date:  2013-10-15       Impact factor: 3.840

10.  Parental comprehension of the benefits/risks of first-line randomised clinical trials in children with solid tumours: a two-stage cross-sectional interview study.

Authors:  Hélène Chappuy; Naim Bouazza; Veronique Minard-Colin; Catherine Patte; Laurence Brugières; Judith Landman-Parker; Anne Auvrignon; Dominique Davous; Hélène Pacquement; Daniel Orbach; Jean Marc Tréluyer; François Doz
Journal:  BMJ Open       Date:  2013-05-28       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.